Disclosure of payments made to HCPs

As of 1 January 2016, we globally ended the practice of making payments to healthcare professionals (HCPs) to speak about our prescription medicines and vaccines to audiences who can prescribe or who can influence prescribing. We also ended the practice of providing direct financial support for individual HCPs to attend medical conferences.

We acknowledge the importance of increased transparency and of putting the patient at the centre of every decision we take.

In many countries, we already publish payments made to HCPs. For example, in Australia, the EU, Japan, and the USA, we publish payments in line with local government regulation or industry association Codes.

We are continuing to work towards increased transparency in other countries as industry associations or governments establish specific guidelines for disclosure.

In Canada, we committed to disclosure of payments to HCPs beginning in 2017. We also continue to work towards publishing global aggregate figures on payments to HCPs for activities such as advisory services and clinical research.